Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Bahnson

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
The Journal of Urology|December 1, 1994
Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapyR R Bahnson, M Becich, M S Ernstoff, et al.
Urology|June 1, 1997
Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomyA K Nangia, B R Konety, S Wachtel, et al.
The Journal of Urology|April 1, 1988
Differences in values obtained with 2 assays of prostate specific antigenG L Hortin, R R Bahnson, M Daft, et al.
Molecular Pharmacology|March 1, 1994
Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cellsY Y Yang, E S Woo, C E Reese, et al.
Toxicology and Applied Pharmacology|March 1, 1994
Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserumS M Kuo, Y Kondo, J M DeFilippo, et al.
Archives of Pathology & Laboratory Medicine|August 3, 2000
Carcinosarcoma of the urinary bladder--an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literatureD Y Baschinsky, J H Chen, M S Vadmal, et al.
The Journal of Urology|July 1, 1995
Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group studyD B Glazier, R R Bahnson, D G McLeod, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysisD L Trump, D C Smith, D Stiff, et al.
Cancer Research|April 1, 1996
Bladder cancer-associated nuclear matrix proteinsR H Getzenberg, B R Konety, T A Oeler, et al.
Urology|February 1, 1992
Interferon-induced reversible acute renal failure with nephrotic syndromeS Nair, M S Ernstoff, R R Bahnson, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
The Journal of Urology|December 1, 1994
Absence of immunohistochemical metallothionein staining in bladder tumor specimens predicts response to neoadjuvant cisplatin, methotrexate and vinblastine chemotherapyR R Bahnson, M Becich, M S Ernstoff, et al.
Urology|June 1, 1997
Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomyA K Nangia, B R Konety, S Wachtel, et al.
The Journal of Urology|April 1, 1988
Differences in values obtained with 2 assays of prostate specific antigenG L Hortin, R R Bahnson, M Daft, et al.
Molecular Pharmacology|March 1, 1994
Human metallothionein isoform gene expression in cisplatin-sensitive and resistant cellsY Y Yang, E S Woo, C E Reese, et al.
Toxicology and Applied Pharmacology|March 1, 1994
Subcellular localization of metallothionein IIA in human bladder tumor cells using a novel epitope-specific antiserumS M Kuo, Y Kondo, J M DeFilippo, et al.
Archives of Pathology & Laboratory Medicine|August 3, 2000
Carcinosarcoma of the urinary bladder--an aggressive tumor with diverse histogenesis. A clinicopathologic study of 4 cases and review of the literatureD Y Baschinsky, J H Chen, M S Vadmal, et al.
The Journal of Urology|July 1, 1995
Intravesical recombinant tumor necrosis factor in the treatment of superficial bladder cancer: an Eastern Cooperative Oncology Group studyD B Glazier, R R Bahnson, D G McLeod, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysisD L Trump, D C Smith, D Stiff, et al.
Cancer Research|April 1, 1996
Bladder cancer-associated nuclear matrix proteinsR H Getzenberg, B R Konety, T A Oeler, et al.
Urology|February 1, 1992
Interferon-induced reversible acute renal failure with nephrotic syndromeS Nair, M S Ernstoff, R R Bahnson, et al.
Pageof 8